Cure
Non-Profit & Charitable Organizations · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 58113, Raleigh, North Carolina, 2...Phone Number
(919) 885-5264Website
www.acureinsight.orgRevenue
<$5 MillionIndustry
About Cure
A Cure In Sight is an independent organization dedicated to providing resources and support for patients and families affected by ocular melanoma, also known as uveal melanoma. The organization empowers individuals navigating this rare eye cancer diagnosis by offering reliable information on treatment options and access to clinical trials. A Cure In Sight fosters a strong community for patients and caregivers to connect and encourages research initiatives aimed at improving treatment outcomes. With a commitment to clarity, compassion, and support, A Cure In Sight plays a vital role in enhancing the journey of those impacted by ocular melanoma.Explore more
Cure Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cure
Compare insights from companies similar to Cure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cure Tech Stack
A closer look at the technologies used by Cure
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Cure
Sign Up For FreeTo access detailed company insights
A Cure In Sight is an independent organization dedicated to providing resources and support for patients and families affected by ocular melanoma, also known as uveal melanoma. The organization empowers individuals navigating this rare eye cancer diagnosis by offering reliable information on treatment options and access to clinical trials. A Cure I... Read More
